Executive Summary
Experts are urging West African countries to leverage the African Continental Free Trade Area (AfCFTA) to reduce dependence on imported medicines, which currently accounts for up to 95% of the continent's supply. Stakeholders at the Pharma West Africa Exhibition and Conference 2026 in Lagos lamented that 30-60% of pharmaceutical manufacturing capacity in Africa remains idle despite growing healthcare needs. Pharm. Ahmed Yakasai, Chairman of the Planning Committee and former President of the Pharmaceutical Society of Nigeria (PSN), highlighted the weaknesses in global supply chains exposed by the COVID-19 pandemic. Dr. Olamide Okulaja, Chief Growth Officer at Maisha Meds International, questioned why Africa imports over 70% of its medicines despite having local factories and expertise. Participants from Liberia, Sierra Leone, and Ghana attended the event, emphasizing the need for regional collaboration to strengthen local manufacturing and harmonize regulations.
- West Africa can reduce its 95% medicine import reliance by leveraging the AfCFTA's 1.3 billion consumer market to boost local manufacturing.
What Is Driving The Story?
- High dependence on imported medicines.
- Underutilized pharmaceutical manufacturing capacity.
- Opportunity presented by the AfCFTA.